Potential treatment effect of the SQ tree SLIT‐tablet on pollen food syndrome caused by apple
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Celgene
This publication has 8 references indexed in Scilit:
- Birch pollen allergy in EuropeAllergy, 2019
- The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trialJournal of Allergy and Clinical Immunology, 2019
- Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergyClinical and Translational Allergy, 2017
- EAACI Molecular Allergology User's GuidePediatric Allergy and Immunology, 2016
- Position paper of the EAACI: food allergy due to immunological cross‐reactions with common inhalant allergensAllergy, 2015
- Anaphylaxis: guidelines from the European Academy of Allergy and Clinical ImmunologyAllergy, 2014
- Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodiesJournal of Allergy and Clinical Immunology, 2011
- Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1Journal of Allergy and Clinical Immunology, 2007